This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

PROGRAM

The INMC program and scientific advisory board committee are developing an exciting and clinical-based innovative program discussion that will address hot topics in NanoMedicine and Regenerative Medicine with an overarching goal to advance the quality of patient’s life. Please visit us frequently for program updates! 

Disclaimer: Program / Topics may change depending on the committee’s and market feedback.

INMC 2019 OBJECTIVES:

  • INMC is aiming to focuses on nanomedicine and regenerative medicine towards clinical trials and commercialization, innovations, regulatory pathways and health policy.

  • INMC supports the establishment of Houston as the premier global nano-medical hub, attracting the worlds best and brightest and fostering the ongoing development of talent in this dynamically evolving field.

  • Facilitate the advancement of clinical trial product development and patient recruitment for nanomedicines and regenerative medicines.

  • Develop session(s) and panel(s) that would address regulatory science, health policy, and manufacturing in the clinical trial for nanomedicine and regenerative medicine.

  • Create an INMC Conference as an investment platform for nanomedicine and regenerative medicine companies to support their product translation through clinical trials.

  • Creating conversations between life sciences scientists, medical professionals, engineers, investors, regulatory agencies, small to medium-sized enterprises and pharmaceutical companies.

  • Provides a unique opportunity to the academic community to investigate their research in the clinical trial pipeline.

 

Program Topics:

CLINICAL NANOMEDICINE AND REGENERATIVE MEDICINE

REGENERATIVE

  • Tissue Engineering
  • Cell Transplantation
  • Organ Generation
  • Decellularization and recellularization of bio-scaffold

DIAGNOSTICS

  • Nanotools
  • Nano/ Microfluidics
  • Rapid-diagnostic Devices
  • Imaging Modalities
  • Nano Implantable Senors

THERAPEUTICS

  • Cell, Gene and Tissue Therapies
  • Chemotherapeutics Drugs
  • Organ Regeneration
  • RNA-Targeting Therapies
  • NanoAntibiotics
  • Sustained Drug Delivery
  • Targeted Drug Delivery
  • Nano Therapeutic Drug Delivery
  • Nano Implantable Senors

VACCINES

  • Infectious Diseases
  • Tropical Diseases
  • Oncology Diseases 
  • Allergies
  • DNA Vaccines

BIOMATERIALS

  • Biodegradable Polymers
  • Bioseparation Materials
  • Biomaterial Properties

 

Fundamentals of Biodistribution 

  • Predicting Drug Safety and Efficacy
  • Stem Cells for Drug discovery, Toxicity Testing, and Disease Modeling
  • Nano-Toxicology
  • Environmental Toxicology
  • Occupational Health

MFG IN CLINICAL TRIALS 

  • Technical Challenges in Clinical Trials (Phase I-III)
  • FDA Regulatory Positions on Nanomedicine and Regenerative Medicine
  • Continous Manufacturing in Nanomedicine and Regenerative Medicine
  • Advanced Robotics and Intelligent Automation Technologies
  • Quality Control and Quality Assurance Technologies and Methodologies
  • Commercial Manufacturing and Contract Manufacturing for Nanomedicine, Gene and Cell Therapy Products

 

Disclaimer: Program / Topics may change depending on the committee’s and market feedback